Pneumococcal Vaccination Utilization Among Hispanic Long-Term Colorectal Cancer Survivors: Cross-Sectional Assessment of Claims
| Autor: | James D. Murphy, Jill Waalen, Vinit Nalawade, Ryan J Moran, Melody K. Schiaffino |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
020205 medical informatics Ethnic group Health Informatics 02 engineering and technology preventive medicine Logistic regression 03 medical and health sciences Underserved Population 0302 clinical medicine Survivorship curve Epidemiology 0202 electrical engineering electronic engineering information engineering medicine cancer survivors 030212 general & internal medicine Cause of death Preventive healthcare Original Paper business.industry Public Health Environmental and Occupational Health pneumococcal vaccines Vaccination medicare Hispanic Americans business Demography |
| Zdroj: | JMIR Public Health and Surveillance |
| ISSN: | 2369-2960 |
| Popis: | Background Colorectal cancer (CRC) is the second leading cancer-related cause of death in the United States. However, survivorship has been increasing. Both cancer survivors and underserved populations experience unique health-related challenges and disparities that may exist among long-term CRC survivors as it relates to routine preventive care, specifically pneumococcal (PNM) vaccination. Objective The aim of this study was to explore the relationship between long-term CRC survival and the receipt of PNM vaccine among Hispanic Medicare recipients compared with non-Hispanic populations. Methods This study is a cross-sectional analysis of the Surveillance, Epidemiology, and End Results (SEER)-Medicare claims data examining ethnic differences in the receipt of PNM vaccination among long-term CRC survivors. Multivariable logistic regression models considered Hispanic ethnicity while controlling for sociodemographic characteristics, comorbidity score, age, tumor stage, and SEER registry. Results Our sample revealed 32,501 long-term CRC survivors, and 1509 identified as Hispanic (4.64%) based on an established SEER algorithm. In total, 16,252 CRC survivors, or 50.00% of our sample, received a PNM vaccination. We found that Hispanic CRC survivors had 10% decreased odds of having received a PNM vaccine compared with non-Hispanic survivors (P=.03). Conclusions Disparities likely exist in the utilization of PNM vaccination among long-term CRC survivors. Among Medicare beneficiaries, the use of claims data regarding PNM vaccination highlights the relatively poor utilization of guideline-directed preventive care. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|